Search results
Striving to revolutionize mental health research. Through a precision psychiatry approach and rich pipeline, we are committed to transforming the mental health landscape. Read more.
Boehringer Ingelheim is a globally operating company, with 146 subsidiaries around the globe. The company's largest site and corporate headquarters is in Ingelheim am Rhein near Mainz and Frankfurt, Germany.
Coast-to-Coast Animal Care. More than 3,000 people power Boehringer Ingelheim Animal Health in the United States, focused on preventing disease and championing innovation. A part of a larger, family-owned company with a rich global history, Boehringer Ingelheim lives at the intersection of the bond that people and animals share.
Boehringer Ingelheim. We have been transforming lives in healthcare since 1885. Our 53,500 employees in 130 markets create value through innovation by infusing long-term, sustainable thinking into our Human Pharma and Animal Health units.
Boehringer Ingelheim is a research-driven group of companies dedicated to the discovery, development, manufacture and marketing of innovative health care products. As a global leader in the animal health industry, we are working on first-in-class innovation for the prediction, prevention, and treatment of diseases in animals.
AI is revolutionizing industries worldwide, but how is it impacting the pharmaceutical sector? Find out how Boehringer Ingelheim is leveraging the power of AI to optimise operations, accelerate research and drive innovation.
Boehringer Ingelheim | 1,817,014 followers on LinkedIn. Our people are our strength. And, together with over 53,000 colleagues, we're creating the next breakthrough in the world of health...
Boehringer Ingelheim is dedicated to providing innovative prescription medication products that bring more health to patients and their families. Aggrenox ® (aspirin/extended-release dipyridamole)
1 day ago · Boehringer Ingelheim has acquired drug discovery and development company Nerio Therapeutics in a $1.3bn deal. The acquisition bolsters Boehringer's immuno-oncology pipeline with Nerio's new PTPN2 ...
Discover Boehringer Ingelheim US Medical and Clinical Resources and explore information on our medical research, clinical developments, and clinical trials.
